Table 1 Comparison of the baseline data between the two groups
Measures | CN (n = 149) | AT (n = 152) | P |
|---|---|---|---|
Sex, N (%) | 0.279 | ||
Male | 18 (12.1%) | 25 (16.4%) | |
Female | 131 (87.9%) | 127 (83.6%) | |
Age, median (Q1,Q3), years | 58 (51, 63) | 60 (53, 65) | 0.127 |
Height, median (Q1,Q3), cm | 158 (154, 161) | 157 (153.5, 161.5) | 0.808 |
Weight, median (Q1,Q3), kg | 60 (55, 65) | 60 (54.3, 65) | 0.773 |
BMI, median (Q1,Q3), kg/m2 | 24.4 (22.2, 26.1) | 24.4 (21.9, 26.6) | 0.954 |
Disease course, median (Q1,Q3), months | 46 (24, 72) | 48 (24, 84) | 0.647 |
WOMAC scorea, median (Q1,Q3) | 34 (25, 45) | 30 (18, 44) | 0.032 |
JOA scoreb, median (Q1,Q3) | 75 (70, 85) | 75 (70, 85) | 0.754 |
Lysholm knee scoreb, median (Q1,Q3) | 59 (50, 66) | 58 (47, 67.5) | 0.935 |
VAS scorea, mean (SD) | 56.1 ± 16.6 | 55.9 ± 18.3 | 0.939 |
SF-36 scoreb, median (Q1,Q3) | 455.5 (336.3, 569.7) | 461.65 (369.6, 581.5) | 0.358 |